Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds VolitionRx Reports FY22 Cash $10.9M

VolitionRx Reports FY22 Cash $10.9M

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

byBenzinga Newsdesk

March 15, 2023

1 minute read

Cash and cash equivalents as of December 31, 2022 totaled approximately $10.9 million.

Sony Clinches Historic $600M Deal for Michael Jackson’s Music Catalog

By Anusuya Lahiri

February 12, 9:16 AM

Sony Group Corp (NYSE: SONY) to acquire 50% of Michael Jackson's music catalog for $600 million, solidifying his legacy and Sony's financial growth.

SONY

News

Sintx Announces New Antibacterial Biomedical Patents And Expansion Of Intellectual Property Portfolio

By Benzinga Newsdesk

October 4, 11:08 AM

SALT LAKE CITY, Oct. 04, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer (OEM) of advanced ceramic

SINT

Credit Suisse Assumes Skyworks Solutions at Outperform, Announces Price Target of $125

By Benzinga Newsdesk

November 16, 5:41 AM

Credit Suisse analyst Chris Caso assumes Skyworks Solutions (NASDAQ:SWKS) with a Outperform rating and announces Price Target of $125.

SWKS

General Dynamics Unit Wins $1.076B Contract Modification From US Navy For Virginia-Class Submarines

By Nabaparna Bhattacharya

May 24, 6:58 AM

General Dynamics Corporation’s (NYSE:GD) unit General Dynamics Electric Boat gets a $1.076 billion contract modification from the U.S. Navy. The order…

VolitionRx Reports FY22 Cash $10.9M

Related Posts

Sony Clinches Historic $600M Deal for Michael Jackson’s Music Catalog

Sintx Announces New Antibacterial Biomedical Patents And Expansion Of Intellectual Property Portfolio

Credit Suisse Assumes Skyworks Solutions at Outperform, Announces Price Target of $125

General Dynamics Unit Wins $1.076B Contract Modification From US Navy For Virginia-Class Submarines